Prevalence of MET exon 14-mutations or MET amplification in non-small cell lung cancer in Swiss patients

被引：0
|
作者：
Prince, S. Savic [1 ]
Bihl, M. [1 ]
Eppenberger-Castori, S. [1 ]
Matter, M. S. [1 ]
Zellweger, N. [2 ]
Rothschild, S. I. [2 ]
Bubendorf, L. [1 ]
机构：
[1] Univ Hosp Basel, Inst Med Genet & Pathol, Pathol, Basel, Switzerland
[2] Univ Hosp Basel, Dept Oncol, Basel, Switzerland
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4P
引用
收藏
页码：S700 / S700
页数：1
相关论文
共 50 条
  • [1] MET exon 14 skipping mutations in advanced non-small cell lung cancer (NSCLC) are not associated with MET amplification and overexpression
    Gimenez-Capitan, Ana
    Teixido, Cristina
    Aguado, Cristina
    Rodriguez, Sonia
    Bertran-Alamillo, Jordi
    Castellvi, Josep
    Yeste, Zaira
    Perez, Ana
    Rosell, Rafael
    Molina-Vila, Miguel Angel
    CANCER RESEARCH, 2017, 77
  • [2] Management of Non-small Cell Lung Cancer Patients with MET Exon 14 Skipping Mutations
    Huang, Caiwen
    Zou, Qihua
    Liu, Hui
    Qiu, Bo
    Li, Qiwen
    Lin, Yongbin
    Liang, Ying
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (04)
  • [3] Management of Non-small Cell Lung Cancer Patients with MET Exon 14 Skipping Mutations
    Caiwen Huang
    Qihua Zou
    Hui Liu
    Bo Qiu
    Qiwen Li
    Yongbin Lin
    Ying Liang
    Current Treatment Options in Oncology, 2020, 21
  • [4] MET targeted therapy in non-small cell lung cancer patients with MET exon 14-skipping mutations
    Jorgensen, Jan Trost
    Urbanska, Edyta M.
    Mollerup, Jens
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (04) : 940 - 946
  • [5] Coexistence of MET exon 14 mutations with EGFR mutations in non-small cell lung cancer
    Li, Wen-Feng
    Kang, Jin
    Zhang, Xu-Chao
    Jian, Su
    Chen, Huajun
    Wang, Zhen
    Wang, Bin-Chao
    Zhou, Qing
    Tu, Hai-Yan
    Wu, Yi-Long
    Yang, Jin-Ji
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations
    Santarpia, Mariacarmela
    Massafra, Marco
    Gebbia, Vittorio
    D'Aquino, Antonio
    Garipoli, Claudia
    Altavilla, Giuseppe
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (03) : 1536 - +
  • [7] Tepotinib in Non-Small Cell Lung Cancer with MET Exon 14-Skipping Mutations or MET Amplification: a Phase 2 Trial in Progress
    Paik, P.
    Sakai, H.
    Bruns, R.
    Scheele, J.
    Straub, J.
    Felip, E.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1046 - S1046
  • [8] MET Exon 14 Skipping in Non-Small Cell Lung Cancer
    Heist, Rebecca S.
    Shim, Hyo Sup
    Gingipally, Shalini
    Mino-Kenudson, Mari
    Le, Long
    Gainor, Justin F.
    Zheng, Zongli
    Aryee, Martin
    Xia, Junfeng
    Jia, Peilin
    Jin, Hailing
    Zhao, Zhongming
    Pao, Gwilliam
    Engelman, Jeffrey A.
    Iafrate, A. John
    ONCOLOGIST, 2016, 21 (04): : 481 - 486
  • [9] Comprehensive characterization of MET exon 14 skipping mutations in non-small cell lung cancer
    Wu, Xue
    Zhang, Yaru
    Pang, Jiaohui
    Lin, Li
    Yin, Jiani C.
    Tang, Haimeng
    Shao, Yang
    CANCER RESEARCH, 2023, 83 (07)
  • [10] Cytomorphology of Non-Small Cell Lung Carcinoma with MET Exon 14 Skipping Mutations
    Labiano, Tania
    Echegoyen, Ana
    Moneo, Marta
    Elizalde, Jesus
    Guerrero, David
    LABORATORY INVESTIGATION, 2024, 104 (03) : S438 - S439
12345